ID:NOS3_HUMAN DESCRIPTION: RecName: Full=Nitric oxide synthase, endothelial; EC=1.14.13.39; AltName: Full=Constitutive NOS; Short=cNOS; AltName: Full=EC-NOS; AltName: Full=Endothelial NOS; Short=eNOS; AltName: Full=NOS type III; Short=NOSIII; FUNCTION: Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets. FUNCTION: Isoform eNOS13C: Lacks eNOS activity, dominant-negative form that may down-regulate eNOS activity by forming heterodimers with isoform 1. CATALYTIC ACTIVITY: 2 L-arginine + 3 NADPH + 4 O(2) = 2 L- citrulline + 2 nitric oxide + 3 NADP(+) + 4 H(2)O. COFACTOR: Heme group. COFACTOR: Binds 1 FAD. COFACTOR: Binds 1 FMN. COFACTOR: Tetrahydrobiopterin (BH4). May stabilize the dimeric form of the enzyme. ENZYME REGULATION: Stimulated by calcium/calmodulin. Inhibited by NOSIP and NOSTRIN. SUBUNIT: Homodimer. Interacts with NOSIP and NOSTRIN. INTERACTION: Q16543:CDC37; NbExp=4; IntAct=EBI-1391623, EBI-295634; Q8IVI9:NOSTRIN; NbExp=7; IntAct=EBI-1391623, EBI-1391643; P50502:ST13; NbExp=3; IntAct=EBI-1391623, EBI-357285; SUBCELLULAR LOCATION: Cell membrane. Membrane, caveola. Cytoplasm, cytoskeleton. Golgi apparatus. Note=Specifically associates with actin cytoskeleton in the G2 phase of the cell cycle; which is favored by interaction with NOSIP and results in a reduced enzymatic activity. TISSUE SPECIFICITY: Platelets, placenta, liver and kidney. PTM: Phosphorylation by AMPK at Ser-1177 in the presence of Ca(2+)-calmodulin (CaM) activates activity. In absence of Ca(2+)- calmodulin, AMPK also phosphorylates Thr-495, resulting in inhibition of activity (By similarity). Phosphorylation of Ser-114 by CDK5 reduces activity. POLYMORPHISM: Variation in NOS3 seem to be associated with susceptibility to coronary spasm. SIMILARITY: Belongs to the NOS family. SIMILARITY: Contains 1 FAD-binding FR-type domain. SIMILARITY: Contains 1 flavodoxin-like domain. WEB RESOURCE: Name=Wikipedia; Note=Nitric oxide synthase entry; URL="http://en.wikipedia.org/wiki/Nitric_oxide_synthase"; WEB RESOURCE: Name=GeneReviews; URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/NOS3"; WEB RESOURCE: Name=SeattleSNPs; URL="http://pga.gs.washington.edu/data/nos3/";
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
ModBase Predicted Comparative 3D Structure on P29474
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Biological Process: GO:0001525 angiogenesis GO:0001542 ovulation from ovarian follicle GO:0001701 in utero embryonic development GO:0001974 blood vessel remodeling GO:0002028 regulation of sodium ion transport GO:0003057 regulation of the force of heart contraction by chemical signal GO:0003100 regulation of systemic arterial blood pressure by endothelin GO:0006527 arginine catabolic process GO:0006809 nitric oxide biosynthetic process GO:0007005 mitochondrion organization GO:0007263 nitric oxide mediated signal transduction GO:0008217 regulation of blood pressure GO:0008285 negative regulation of cell proliferation GO:0009408 response to heat GO:0010544 negative regulation of platelet activation GO:0014740 negative regulation of muscle hyperplasia GO:0014806 smooth muscle hyperplasia GO:0019430 removal of superoxide radicals GO:0030324 lung development GO:0031284 positive regulation of guanylate cyclase activity GO:0031663 lipopolysaccharide-mediated signaling pathway GO:0034405 response to fluid shear stress GO:0042311 vasodilation GO:0043267 negative regulation of potassium ion transport GO:0043536 positive regulation of blood vessel endothelial cell migration GO:0043542 endothelial cell migration GO:0045454 cell redox homeostasis GO:0045766 positive regulation of angiogenesis GO:0045776 negative regulation of blood pressure GO:0050880 regulation of blood vessel size GO:0050999 regulation of nitric-oxide synthase activity GO:0051186 cofactor metabolic process GO:0051346 negative regulation of hydrolase activity GO:0051926 negative regulation of calcium ion transport GO:0055114 oxidation-reduction process GO:1902042 negative regulation of extrinsic apoptotic signaling pathway via death domain receptors